Acne

The FDA ( Food and Drug Administration ) has approved Iressa ( Gefitinib ) for the first-line treatment of patients...


Epiduo Forte ( Adapalene and Benzoyl peroxide ) Gel, 0.3%/2.5% has been approved by the FDA ( Food and Drug...


Afatinib ( Giotrif ) was compared with standard Platinum-based doublet chemotherapy in two large, randomized phase III studies, ie, LUX-Lung...


The European Commission has approved Humira ( Adalimumab ) for the treatment of active moderate to severe hidradenitis suppurativa...


The FDA ( Food and Drug Administration ) is warning that certain over-the-counter ( OTC ) topical acne products can...


Certain acne treatments can, in rare instances, cause severe allergic reactions that are potentially life-threatening. The Food and Drug Administration (...


The treatment of drug sensitive strains of tuberculosis ( TB ) requires minimum duration of 6 months. However, for multiple...


Results from a phase 3 pivotal study demonstrating that Adalimumab ( Humira ) is effective in reducing common clinical signs...


The Food and Drug Administration ( FDA ) has approved two new drugs, Tafinlar ( Dabrafenib ) and Mekinist (...


There are no standardized therapeutic recommendations for the treatment of demodicidosis. Although topical therapy alone is often not sufficiently effective,...


The objective of a study was to evaluate the efficacy of Ivermectin and combined Ivermectin and Metronidazole therapy in the...


Angiomyolipomas are slow-growing tumours associated with constitutive activation of mammalian target of Rapamycin ( mTOR ), and are common in...


Following a Europe-wide review of Cyproterone acetate with Ethinylestradiol ( Co-cyprindiol ), the balance of benefits and risks of Dianette...


The risk of foetal malformation with oral retinoids is extremely high, even when used at a low dose or for...


The French medicines agency has announced its plan to suspend the marketing authorisation for Diane 35 ( Cyproterone acetate 2...


The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee ( PRAC ) has concluded that the benefits of Diane 35 (...


Merck Serono has announced that the European Commission ( EU ) has approved the type II variation to amend the...


The Committee for Medicinal Products for Human Use ( CHMP ) has adopted a positive opinion, recommending the granting of...


Celgene has announced results of phase II trial ( BCT-001 ) on Apremilast, a oral targeted inhibitor of phosphodiesterase 4...


The 2-year follow-up results for a randomized placebo-controlled study of 47 patients with multidrug-resistant pulmonary tuberculosis treated with either the...